🔗 Share this article

A shadow market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Investigational Drug Acquiring Popularity Online

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Followers are encouraged to contact these profiles directly for supplier links, while also obtaining promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where groups with thousands of participants share “before and after” images, injection guides and assertions of rapid British shipping. Vendors promote the drug there before directing customers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Experts Voice Worries

However, doctors and chemists have cautions that the distribution of what remains an unapproved drug in the UK is worrisome and could lead to users administering products of uncertain source.

Several experts stated the popularity for retatrutide could be connected to the rising price of approved weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on social media or messaging apps is illegal in the UK, as it is an unlicensed medication that cannot be promoted or distributed for human use under the British medical regulations.

Several influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach pharmaceutical, advertising, and consumer laws, risking penalties, legal action or imprisonment.

Service Reaction and Material Removal

Based on TikTok, the platform has taken down problematic content and prohibited associated keywords and search suggestions. The company stated it was dedicated to keeping the service safe and investing in enhancing enforcement strategies.

Online Marketplace Activities

Research also found communities with up to 9,000 members marketing retatrutide using the platform's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” instantly displays channels with thousands of members, filled with photos of slimming results, positive testimonials and detailed instructions for mixing or administering at home.

After minutes of joining one community, a vendor shared contact information, where most transactions take place. The seller sent an instruction manual and guaranteed shipping within two days. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about weight, health issues or past usage.

Item Information and Pricing

Inside these communities, posts show dark colored parcels with Royal Mail stickers, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with purified liquid, or pre-filled injectors typically priced at £160 for 20mg. When asked how long a pen should last, sellers give contradictory answers ranging from a several days to “depends on your body”.

Platform Moderation and Safety Measures

A representative for the messaging service said it actively monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering substances they cannot confirm. Even if the science behind this drug is valid, these online products may not include what they advertise,” stated Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the increase in interest to recent cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake treatments are extremely risky. You cannot know what’s inside or whether the conditions they were made in was clean,” she explained.

Her staff has previously seen patients injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may subject patients to potentially serious medical dangers”.